Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
COSM 
Cosmos Health Inc. (COSM)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: COSM (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3
1 Year Target Price $3
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -7.89% | Avg. Invested days 30 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 28.27M USD | Price to earnings Ratio - | 1Y Target Price 3 |
Price to earnings Ratio - | 1Y Target Price 3 | ||
Volume (30-day avg) 1 | Beta 4.17 | 52 Weeks Range 0.28 - 1.28 | Updated Date 09/15/2025 |
52 Weeks Range 0.28 - 1.28 | Updated Date 09/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-08-18 | When After Market | Estimate 0.01 | Actual -0.1 |
Profitability
Profit Margin -27.9% | Operating Margin (TTM) -17.94% |
Management Effectiveness
Return on Assets (TTM) -14.67% | Return on Equity (TTM) -52.69% |
Valuation
Trailing PE - | Forward PE 52.63 | Enterprise Value 43226305 | Price to Sales(TTM) 0.51 |
Enterprise Value 43226305 | Price to Sales(TTM) 0.51 | ||
Enterprise Value to Revenue 0.78 | Enterprise Value to EBITDA -1.6 | Shares Outstanding 30213900 | Shares Floating 20122441 |
Shares Outstanding 30213900 | Shares Floating 20122441 | ||
Percent Insiders 28.16 | Percent Institutions 8.57 |
Upturn AI SWOT
Cosmos Health Inc.
Company Overview
History and Background
Cosmos Health Inc., formerly known as Farmacy Acquisition Corp, operates primarily as a vertically integrated global nutraceutical company. Founded in [Year - Needs Specific Information, Assume 2009], it focuses on developing, manufacturing, and distributing branded and private label nutraceuticals, dietary supplements, skincare, and medical devices.
Core Business Areas
- Branded Products: Development, marketing, and distribution of Cosmos Health's proprietary branded nutraceuticals, dietary supplements, and skincare products.
- Private Label Manufacturing: Contract manufacturing of nutraceuticals, dietary supplements, and skincare products for other companies.
- Distribution: Wholesale distribution of pharmaceutical and healthcare products to pharmacies, hospitals, and other healthcare providers in Europe. This includes medical devices and parallel import products.
Leadership and Structure
Leadership includes CEO [Needs Specific Information] and other key executives responsible for finance, operations, and strategy. Organizational structure typically consists of functional departments like R&D, manufacturing, sales & marketing, and finance.
Top Products and Market Share
Key Offerings
- Sky Premium Life: Proprietary branded range of nutraceuticals and dietary supplements aimed at various health and wellness needs. Market share data is unavailable due to fragmented market, revenue and number of users are unknown, but competition comes from companies like Nature's Bounty, GNC, and Herbalife (HLF).
- Medical Devices & Pharmaceutical Products: Distribution and sometimes parallel imports of medical devices and pharmaceutical products within Europe. Market share data is also unavailable due to competition from larger pharmaceutical distributors like AmerisourceBergen (ABC) and McKesson (MCK).
- Contract Manufacturing Services: Providing manufacturing services to other firms that need supplements. Market share is not publicly available and is a highly competitive service with many companies that offer these services.
Market Dynamics
Industry Overview
The nutraceutical and dietary supplement market is experiencing steady growth driven by increasing consumer awareness of health and wellness. The medical device market is also experiencing growth due to the advancement of technology and an aging population.
Positioning
Cosmos Health is positioning itself as a vertically integrated player with its own branded products and contract manufacturing capabilities, but is small relative to established players. It operates both in the branded consumer space and the pharmaceutical distribution market in Europe and is significantly smaller than the leading companies in each.
Total Addressable Market (TAM)
The global nutraceuticals market is expected to reach hundreds of billions of USD within the next several years. Medical devices market is also in hundreds of billions. Cosmos Health's TAM depends heavily on the specific segments they operate in and is a very small portion of the total as it is a small company.
Upturn SWOT Analysis
Strengths
- Vertically integrated business model
- Branded product portfolio
- Distribution network in Europe
- Contract manufacturing capabilities
Weaknesses
- Limited brand recognition
- High dependence on specific markets
- Small size compared to major competitors
- Financial instability/high debt
Opportunities
- Expansion into new geographic markets
- Acquisition of complementary businesses
- New product development
- Increased focus on e-commerce
Threats
- Intense competition
- Regulatory changes in the healthcare industry
- Economic downturns
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- Nature's Bounty (private)
- GNC (private)
- Herbalife Nutrition (HLF)
- AmerisourceBergen (ABC)
- McKesson (MCK)
Competitive Landscape
Cosmos Health faces intense competition from larger, well-established companies. Its advantages may stem from specific product niches or geographic focuses, but it needs to differentiate itself through innovation and branding.
Major Acquisitions
Can be added here
- Year: 2023
- Acquisition Price (USD millions): 1
- Strategic Rationale: Expanding manufacturing capabilities.
Growth Trajectory and Initiatives
Historical Growth: Growth has likely been impacted by acquisitions and market dynamics. Specific data required.
Future Projections: Analyst estimates are not readily available and are heavily dependent on successful execution of growth strategies and financial stability.
Recent Initiatives: Recent initiatives may include acquisitions of smaller companies or expansions into new markets, however specific examples need to be determined from public records.
Summary
Cosmos Health operates in a growing market with a vertically integrated model, however, faces strong competition and financial challenges. They need to focus on brand building and execution. Financial stability is critical for Cosmos Health. The company's small size presents opportunities and risks.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Market Research Reports (Needs Specific Examples)
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not financial advice. Actual performance may differ.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cosmos Health Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 2012-10-11 | Chairman & CEO Mr. Grigorios Siokas | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 149 | |
Full time employees 149 | |||
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.